Specifically, short-term treatment with IL-6, improved glucose control and insulin sensitivity, whereas long-term treatment with IL-6 contributed to glucose intolerance and insulin resistance (Nieto-Vazquez et al., 2008; Kim et al., 2013). This evidence concerns the gene INS and Insulin resistance.